Retatrutide

11 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Retatrutide
Treatment and conditionWhere it standsTrials
Retatrutide for cardiovascular diseasesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for coronary artery diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for diabetes mellitusPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Retatrutide for insulin resistancePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for kidney failure, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for metabolic diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)12
Retatrutide for osteoarthritis, kneePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for peripheral arterial diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1